Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
117,284,178
-
Shares change
-
+15,907,076
-
Total reported value, excl. options
-
$1,477,314,948
-
Value change
-
+$207,540,039
-
Put/Call ratio
-
88.54%
-
Number of buys
-
104
-
Number of sells
-
-91
-
Price
-
$12.59
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q2 2022
249 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q2 2022.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117,284,178 shares
.
Largest 10 shareholders include BlackRock Inc. (18,561,894 shares), FEDERATED HERMES, INC. (16,022,731 shares), STATE STREET CORP (8,629,427 shares), Bain Capital Life Sciences Investors, LLC (8,415,000 shares), VANGUARD GROUP INC (8,023,967 shares), Chicago Capital, LLC (5,842,906 shares), Fisher Asset Management, LLC (4,288,848 shares), PFM Health Sciences, LP (3,805,370 shares), BLAIR WILLIAM & CO/IL (2,525,526 shares), and EDMOND DE ROTHSCHILD HOLDING S.A. (2,320,000 shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.